With so many shares to choose from on the ASX, it can be hard to decide which ones to buy. The good news is that brokers across the country are doing a lot of the hard work for you.
Three top ASX shares leading brokers have named as buys this week are listed below. Here's why they are bullish on them:
Image Source: Getty Images
Airtasker Ltd (ASX: ART)
According to a note out of Morgans, its analysts have retained their add rating but trimmed their price target slightly on this small jobs marketplace provider's shares to $1.27. This follows the release of a resilient quarterly update last week. Morgans was pleased with the company's performance given how over half its target market was locked down. The Airtasker share price is trading at $1.10 on Monday.
Macquarie Group Ltd (ASX: MQG)
A note out of Citi reveals that its analysts have upgraded this investment bank's shares to a buy rating with an improved price target of $226.00. Citi was pleased with Macquarie's performance in the first half and expects more of the same in the second half. Particularly given how the company is well-placed to benefit from the current energy crisis. Combined with upgraded guidance for commodities revenue and gain on sale revenue in MacCap, the broker has upgraded its earnings estimate for FY 2022 by 17% to $4,145 million. The Macquarie share price is fetching $197.00 today.
ResMed Inc. (ASX: RMD)
Another note out of Morgans reveals that its analysts have retained their add rating but trimmed their price target on this sleep treatment focused medical device company's shares to $40.80. This follows the release of a better than expected first quarter update last week. While the broker acknowledges that supply constraints will limit market share gains from the rival product recall, it is still expecting solid earnings growth over the medium term. The ResMed share price is trading at $35.29 today.
